Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Assessment of plasma dexamethasone level after 1-mg dexamethasone suppression test in adults with obesity
TCTR20220223003Phase 0Completed
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Jul 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 0, open-label, single-arm trial of dexamethasone, sponsored by Ratchadaphiseksomphot Endowment Fund. Primary endpoint: Plasma dexamethasone concentration after 1-mg dexamethasone suppression test. Started Jul 2021; status: completed.
02
Drugs
dexamethasone
Beyond the preview
Go deeper on TCTR20220223003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220223003.